[
  {
    "ts": "2025-11-24T11:00:46+00:00",
    "headline": "Is Weakness In Abbott Laboratories (NYSE:ABT) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?",
    "summary": "With its stock down 2.6% over the past three months, it is easy to disregard Abbott Laboratories (NYSE:ABT). But if you...",
    "url": "https://finance.yahoo.com/news/weakness-abbott-laboratories-nyse-abt-110046282.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "39da76c1-0bcb-37cc-99ba-d28fe3a0c1c3",
      "content": {
        "id": "39da76c1-0bcb-37cc-99ba-d28fe3a0c1c3",
        "contentType": "STORY",
        "title": "Is Weakness In Abbott Laboratories (NYSE:ABT) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?",
        "description": "",
        "summary": "With its stock down 2.6% over the past three months, it is easy to disregard Abbott Laboratories (NYSE:ABT). But if you...",
        "pubDate": "2025-11-24T11:00:46Z",
        "displayTime": "2025-11-24T11:00:46Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/9233d293790357e156ec19f81dd7a7d9",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/7zJOBZ6wPnYKbKPRmWh.qQ--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/9233d293790357e156ec19f81dd7a7d9.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/sc9EgsXKjWnUzlOQpxWhqQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/9233d293790357e156ec19f81dd7a7d9.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/weakness-abbott-laboratories-nyse-abt-110046282.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/weakness-abbott-laboratories-nyse-abt-110046282.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABT"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-24T14:41:00+00:00",
    "headline": "Booking, Carvana upgraded: Wall Street's top analyst calls",
    "summary": "Booking, Carvana upgraded: Wall Street's top analyst calls",
    "url": "https://finance.yahoo.com/news/booking-carvana-upgraded-wall-streets-144100903.html",
    "source": "The Fly",
    "provider": "yfinance",
    "raw": {
      "id": "8429d10b-334f-30c9-bf55-ebf980fc3fc4",
      "content": {
        "id": "8429d10b-334f-30c9-bf55-ebf980fc3fc4",
        "contentType": "STORY",
        "title": "Booking, Carvana upgraded: Wall Street's top analyst calls",
        "description": "",
        "summary": "Booking, Carvana upgraded: Wall Street's top analyst calls",
        "pubDate": "2025-11-24T14:41:00Z",
        "displayTime": "2025-11-24T14:41:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/the_fly_169/5039a5ccc6ec98e1b92bc672330bfcec",
          "originalWidth": 1200,
          "originalHeight": 628,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/YHTvjvqtNAYBPYViMXYCow--~B/aD02Mjg7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/the_fly_169/5039a5ccc6ec98e1b92bc672330bfcec.cf.webp",
              "width": 1200,
              "height": 628,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/J3gfZRz3Jb2im4_aLYVn4g--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/the_fly_169/5039a5ccc6ec98e1b92bc672330bfcec.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Fly",
          "url": "https://thefly.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/booking-carvana-upgraded-wall-streets-144100903.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/booking-carvana-upgraded-wall-streets-144100903.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CVNA"
            },
            {
              "symbol": "MS"
            },
            {
              "symbol": "MS-PQ"
            },
            {
              "symbol": "GOOG"
            },
            {
              "symbol": "WVCCX"
            },
            {
              "symbol": "MRK"
            },
            {
              "symbol": "BKNG"
            },
            {
              "symbol": "JAZZ"
            },
            {
              "symbol": "CDNS"
            },
            {
              "symbol": "EXAS"
            },
            {
              "symbol": "CLH"
            },
            {
              "symbol": "FLUT"
            },
            {
              "symbol": "GOOGL"
            },
            {
              "symbol": "OPAI.PVT"
            },
            {
              "symbol": "H"
            },
            {
              "symbol": "META"
            },
            {
              "symbol": "FROG"
            },
            {
              "symbol": "SNPS"
            },
            {
              "symbol": "QS"
            },
            {
              "symbol": "PCT"
            },
            {
              "symbol": "ABT"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-24T16:05:00+00:00",
    "headline": "Autoimmune Disease Diagnostics Market Competitive Landscape Report 2025: Recent Developments, Company Strategies, Sustainability Benchmarking, Product Launches, Key Persons, and Revenue Forecasts",
    "summary": "The Autoimmune Disease Diagnostics industry is set for significant growth, projected to leap from US$ 5.70 billion in 2024 to US$ 10.63 billion by 2033, at a CAGR of 7.17%. Key growth drivers include a rising need for precise diagnostic tools and a focus on enhanced patient outcomes. Innovations in diagnostic technologies and strategic partnerships among industry leaders are paving the way for improvements. Leading companies like Abbott Laboratories, Bio-Rad, Roche Diagnostics, and Siemens Healt",
    "url": "https://finance.yahoo.com/news/autoimmune-disease-diagnostics-market-competitive-160500543.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "633d6cde-2653-383a-9330-4e01df79a619",
      "content": {
        "id": "633d6cde-2653-383a-9330-4e01df79a619",
        "contentType": "STORY",
        "title": "Autoimmune Disease Diagnostics Market Competitive Landscape Report 2025: Recent Developments, Company Strategies, Sustainability Benchmarking, Product Launches, Key Persons, and Revenue Forecasts",
        "description": "",
        "summary": "The Autoimmune Disease Diagnostics industry is set for significant growth, projected to leap from US$ 5.70 billion in 2024 to US$ 10.63 billion by 2033, at a CAGR of 7.17%. Key growth drivers include a rising need for precise diagnostic tools and a focus on enhanced patient outcomes. Innovations in diagnostic technologies and strategic partnerships among industry leaders are paving the way for improvements. Leading companies like Abbott Laboratories, Bio-Rad, Roche Diagnostics, and Siemens Healt",
        "pubDate": "2025-11-24T16:05:00Z",
        "displayTime": "2025-11-24T16:05:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/689f7f2556ed1294ebe1545d0e3e4698",
          "originalWidth": 600,
          "originalHeight": 400,
          "caption": "Autoimmune Disease Diagnostics Market",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Ea7OWGiJkAcC2OnUCQXR7g--~B/aD00MDA7dz02MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/689f7f2556ed1294ebe1545d0e3e4698.cf.webp",
              "width": 600,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/POF7adXnHiz9PCeaGyHMkw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/689f7f2556ed1294ebe1545d0e3e4698.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/autoimmune-disease-diagnostics-market-competitive-160500543.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/autoimmune-disease-diagnostics-market-competitive-160500543.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABT"
            },
            {
              "symbol": "BIO"
            },
            {
              "symbol": "SHL.DE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]